ISSN: 1520-4391

Journal Home

Journal Guideline

Hematology / the Education Program of the American Society of Hematology Q1 Unclaimed

American Society of Hematology United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hematology / the Education Program of the American Society of Hematology is a journal indexed in SJR in Hematology with an H index of 104. It has a price of 3250 €. It has an SJR impact factor of 1,139 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,139.

Hematology / the Education Program of the American Society of Hematology focuses its scope in these topics and keywords: patients, young, stroke, ready, prime, pregnancygenetics, patient, nhl, natural, syndromes, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Hematology (Q1)

Price

3250 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Hematology / the Education Program of the American Society of Hematology

1,139

SJR Impact factor

104

H Index

102

Total Docs (Last Year)

279

Total Docs (3 years)

0

Total Refs

904

Total Cites (3 years)

279

Citable Docs (3 years)

2.7

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Journal of Hematology and Oncology Q1
Blood Q1
Blood Cancer Journal Q1
The Lancet Haematology Q1
Leukemia Q1

Compare this journals

Aims and Scope

Best articles by citations

A brief, but comprehensive, guide to clonal evolution in aplastic anemia

New insights into treatment of venous thromboembolism

Investigative Tools for Diagnosis and Management

Advances in Biology and Therapy of Multiple Myeloma

Impact of MYC on malignant behavior

Monitoring target-specific oral anticoagulants

Philadelphia Chromosome-Negative Myeloproliferative Disorders: An Historical Perspective

Evidence-Based Guidelines - An Introduction

Chronic Myeloid Leukemia

Alpha thalassemia major - new mutations, intrauterine management, and outcomes

Chronic Myeloid Leukemia Stem Cells

Platelet Transfusions: An Historical Perspective

SHOW MORE ARTICLES

Ham-Wasserman Lecture

Chronic Myeloid Leukemia: An Historical Perspective

Ham-Wasserman Lecture

Anticoagulation in pregnancy complications

Systemic Light-Chain Amyloidosis: Advances in Diagnosis, Prognosis, and Therapy

Childhood and Adolescent Lymphoid and Myeloid Leukemia

Viral-Associated Immune Thrombocytopenic Purpura

Therapeutic targeting of microenvironment in follicular lymphoma

Iron clad: iron homeostasis and the diagnosis of hereditary iron overload

Peripheral T-Cell Lymphomas: An Historical Perspective

Duration of Anticoagulation Therapy for Venous Thromboembolism

Indolent lymphoma: follicular lymphoma and the microenvironment - insights from gene expression profiling